Journal
AUSTRALASIAN JOURNAL OF DERMATOLOGY
Volume 62, Issue 3, Pages 403-406Publisher
WILEY
DOI: 10.1111/ajd.13660
Keywords
cutaneous immune-related adverse effects; lichen planopilaris; lichenoid reaction; scarring alopecia
Categories
Ask authors/readers for more resources
Lichenoid reactions can be a potential severe adverse effect of immune checkpoint inhibitors, with long-term impact on patient's quality of life.
Lichenoid reactions are one of the many cutaneous immune-related adverse events seen with the use of immune checkpoint inhibitors, particularly anti-PD1 inhibitors. We present a rare care of severe lichen planopilaris secondary to pembrolizumab, with progression even after cessation of immunotherapy. It is important to recognise the significant long-term impact of these cutaneous adverse effects on patient's quality of life.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available